0001104659-20-034208.txt : 20200316 0001104659-20-034208.hdr.sgml : 20200316 20200316175100 ACCESSION NUMBER: 0001104659-20-034208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200313 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Jonathan CENTRAL INDEX KEY: 0001779805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 20718496 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY 3RD FL CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 a4.xml 4 X0306 4 2020-03-13 0 0001744659 Akero Therapeutics, Inc. AKRO 0001779805 Young Jonathan C/O AKERO THERAPEUTICS, INC., 170 HARBOR WAY, 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Operating Officer Common Stock 2020-03-13 4 M 0 5035 0.615 A 177518 D Common Stock 2020-03-13 4 M 0 6082 0.615 A 183600 D Common Stock 20000 I By EA Irrevocable Trust Common Stock 20000 I By CM Irrevocable Trust Common Stock 20000 I By JL Irrevocable Trust Stock Option (Right to Buy) 0.615 2020-03-13 4 M 0 5035 0 D 2028-07-29 Common Stock 5035 42796 D Stock Option (Right to Buy) 0.615 2020-03-13 4 M 0 6082 0 D 2028-10-17 Common Stock 6082 94268 D Due to a clerical error in the preparation of the reporting person's Form 3, the reporting person's beneficial ownership was overstated by 60,000 on the Form 3 filed on June 19, 2019 and the Form 4s filed on December 31, 2019 and January 10, 2019 as the 60,000 shares that are indicated as being owned by the EA Irrevocable Trust, CM Irrevocable Trust and JL Irrevocable Trust were not removed from the reporting person's direct ownership total reported in column 5. That error has been corrected in this Form 4. These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. 25% of this option vested on August 1, 2018 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter. Shares vested and became exercisable in equal monthly installments for a period of 48 months following October 1, 2018. /s/ Jonathan Young 2020-03-16